Skip to main content

Animations

MJFF Publications

6981 - 6990 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2021
  • 2023
  • 2022
  • 2019
  • 2020
  • 2019
  • 2023
  • 2015
  • 2018
  • Summary Details
    OPEN
    Title: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.27989
    Citation Count: 62
  • Summary Details
    OPEN
    Title: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.28608
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-023-01433-w
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-022-02488-3
    Citation Count: 38
  • Summary Details
    OPEN
    Title: New aspects of USP30 biology in the regulation of pexophagy
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/15548627.2019.1615304
    Citation Count: 14
  • Summary Details
    OPEN
    Title: USP30 sets a trigger threshold for PINK1–PARKIN amplification of mitochondrial ubiquitylation
    Journal Name: Life Science Alliance
    Publisher: Life Science Alliance, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.26508/lsa.202000768
    Citation Count: 105
  • Summary Details
    OPEN
    Title: Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30141-3
    Citation Count: 112
  • Summary Details
    RESTRICTED
    Title: Challenges of Parkinson's disease GWASs in African people
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00361-7
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Synthesis of Multiring Fused 2-Pyridones via a Nitrene Insertion Reaction: Fluorescent Modulators of α-Synuclein Amyloid Formation
    Journal Name: Organic Letters
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.orglett.5b03190
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Inflammatory bowel disease and risk of Parkinson's disease in Medicare beneficiaries
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.008
    Citation Count: 76
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.